This study demonstrated adequate adherence to SE in a
community treatment setting using a centrally administered
program, risk factor control achieved via use of a structured
patient informational program, SE and ST benefit in the
context of an active claudication medication, the safety of both SE and ST interventions, and the finding that SE is an efficacious intervention for patients with PAD in the aortoiliac
segment.